Sep 22, 09:11
Sep 22, 09:07
100% of moneycontrol users recommend buying Panacea Biotec.
What's your call on Panacea Biotec today?
Read 8 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3162.00||-1.75||3240.00||2420.00||53,869.68|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|Scheme||No. of Shares|
|ICICI Prudential Exports and Other Services Fund (G)||307,268|
|ICICI Prudential Exports and Other Services Fund - Direct Plan (G)||15,302|
RS Software (India) Recommended on Aug 12th 2014
Recommended price 430.00 | Peak from reco 829.30 92.86%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Panacea Biotec is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,240.33 crore.The company has reported a standalone sales of Rs 131.50 crore and a Net Loss of Rs -23.54 crore for the quarter ended Jun 2014.
The company management includes Soshil Kumar Jain - Chairman, Ravinder Jain - Managing Director, Rajesh Jain - Joint Managing Director, Sandeep Jain - Joint Managing Director, Sumit Jain - Director - Operations, R L Narasimhan - Non Executive Director, N N Khamitkar - Non Executive Director, K M Lal - Non Executive Director, A N Saksena - Non Executive Director.
It is listed on the BSE with a BSE Code of 531349 and the NSE with an NSE Code of PANACEABIO.
Its Registered office is at Ambala-Chandigarh Highway , Lalru,Punjab - 140501.
Their Registrars are Skyline Financial Services (p) Ltd.